Xr Securities LLC Bristol Myers Squibb CO Transaction History

Xr Securities LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$48.48 - $57.85 $189,168 - $225,730	3,902 New	3,902 $200,000
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $17,084 - $19,377	-260 Reduced 2.31%	10,973 $760,000
Q4 2022 Jan 03, 2023	BUY	$68.48 - $81.09 $442,997 - $524,571	6,469 Added 135.79%	11,233 $808,000
Q3 2022 Oct 18, 2022	BUY	$0.13 - $76.84 $619 - $366,065	4,764 New	4,764 $339,000
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $305,985 - $366,904	4,977 Added 99.72%	9,968 $728,000
Q4 2021 Jan 10, 2022	SELL	$53.63 - $62.52 $936,969 - $1.09 Million	-17,471 Reduced 77.78%	4,991 $311,000
Q4 2019 Jan 06, 2020	BUY	$49.21 - $64.19 $393,384 - $513,134	7,994 Added 55.25%	22,462 $1.44 Million
Q3 2019 Oct 03, 2019	BUY	$42.77 - $50.71 $175,913 - $208,570	4,113 Added 39.72%	14,468 $734,000
Q2 2019 Jul 10, 2019	BUY	$44.62 - $49.34 $462,040 - $510,915	10,355 New	10,355 $470,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.